¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"lymphocyte activating factor"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
lymphocyte-activating factor
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
primed lymphocyte typing
ÃÊȸ¹Î°¨¸²ÇÁ±¸Çü°áÁ¤
reticular lymphocyte
±×¹°¸²ÇÁ±¸, ¸Á»ó¸²ÇÁ±¸
sensitized lymphocyte
¹Î°¨È¸²ÇÁ±¸
antihemophilic factor
Ç×Ç÷¿ìº´ÀÎÀÚ
antineuritic factor
Ç׽Ű濰ÀÎÀÚ
antipellagra factor
Çׯç¶ó±×¶óÀÎÀÚ
antiphagocytic factor
Çׯ÷½ÄÀÎÀÚ, Ç׎½ÄÀÎÀÚ
antiplatelet factor
Ç×Ç÷¼ÒÆÇÀÎÀÚ
antirachitic factor
Ç×±¸·çº´ÀÎÀÚ
antiscorbutic factor
Ç×±«Ç÷º´ÀÎÀÚ
antisterility factor
Ç׺ÒÀÓÀÎÀÚ
atrial natriuretic factor
½É¹æ³ªÆ®·ýÀÌ´¢ÀÎÀÚ, ½É¹æ¼ÒµãÀÌ´¢ÀÎÀÚ
activation factor
Ȱ¼ºÀÎÀÚ
absorbed dose conversion factor
Èí¼ö¼±·®º¯È¯°è¼ö
alveolar dilution factor
ÆóÆ÷Èñ¼®ÀÎÀÚ, ÇãÆÄ²Ê¸®Èñ¼®ÀÎÀÚ
ÀÌÀü
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
7
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
psychological factor
½É¸®¿ä¼Ò
relaxing factor
ÀÌ¿ÏÀÎÀÚ
resistance factor
³»¼ºÀÎÀÚ, °ßµõÀÎÀÚ
rheumatoid factor
·ù¸¶Æ¼½ºÀÎÀÚ
risk factor
À§ÇèÀÎÀÚ
transforming growth factor
Àüȯ¼ºÀåÀÎÀÚ
vascular endothelial growth factor
Ç÷°ü³»ÇǼºÀåÀÎÀÚ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
sensitized lymphocyte
¹Î°¨¸²ÇÁ±¸
short lived lymphocyte
´Ü»ý¸²ÇÁ±¸, ªÀº¼ö¸í¸²ÇÁ±¸
thymic lymphocyte
°¡½¿»ù¸²ÇÁ±¸
thymus-derived lymphocyte
°¡½¿»ùÀ¯·¡¸²ÇÁ±¸
mixed lymphocyte reaction
¸²ÇÁ±¸È¥ÇÕ¹è¾ç¹ÝÀÀ
mixed lymphocyte culture test
È¥ÇÕ¸²ÇÁ±¸¹è¾ç°Ë»ç
monocyte lymphocyte ratio
´ÜÇÙ±¸¸²ÇÁ±¸ºñÀ²
primed lymphocyte typing
ÃÊȸÇ׿øÀÚ±ØÈĸ²ÇÁ±¸Çüº°È
primed lymphocyte-typing test
°¨ÀÛ¸²ÇÁ±¸Çüº°°Ë»ç
absorbed dose conversion factor
Èí¼ö¼±·®º¯È¯°è¼ö
activation factor
Ȱ¼ºÀÎÀÚ
alveolar dilution factor
ÆóÆ÷Èñ¼®ÀÎÀÚ, ÇãÆÄ²Ê¸®Èñ¼®ÀÎÀÚ
amplification factor
ÁõÆøÀÎÀÚ
antihemophlic factor
Ç×Ç÷¿ìº´ÀÎÀÚ
antineuritic factor
Ç׽Ű濰ÀÎÀÚ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
T lymphocyte
T ¸²ÇÁ±¸
T-lymphocyte
T-Àӯı¸
anti-lymphocyte globulin
¸²ÇÁ±¸ Çױ۷κҸ°
antigen, lymphocyte defined (LD)
¸²ÇÁ±¸ Ç¥¸éÇ׿ø, LDÇ׿ø
granulocyte-monocyte-lymphocyte antigens
°ú¸³±¸´Ü±¸¸²ÇÁ±¸Ç׿ø
granulocyte-platelet-lymphocyte antigens
°ú¸³±¸Ç÷¼ÒÆÇ¸²ÇÁ±¸Ç׿ø
hodgkins disease,lymphocyte predominance
¸²ÇÁ±¸ ÇöÀúÇü
primed lymphocyte
ÃÊȸ°¨ÀÛ ¸²ÇÁ±¸
primed lymphocyte typing
ÃÊȸÇ׿øÀÚ±ØÈÄ ¸²ÇÁ±¸Çüº°È
primed lymphocyte-typing test
ÃÊȸ°¨ÀÛ ¸²ÇÁ±¸ÀÌ¿ë Çüº°°Ë»ç
AHF=£¾antihemophilic factor
Ç×Ç÷¿ìÀÎÀÚ.
B cell differentiation factor (BCDF)
B¼¼Æ÷ ºÐÈÀ¯¹ßÀÎÀÚ
B cell growth factor
B ¼¼Æ÷¼ºÀåÀÎÀÚ
B cell growth factor (BCGF)
B¼¼Æ÷ Áõ½ÄÃËÁøÀÎÀÚ
B cell stimulating factor (BSF)
B¼¼Æ÷ ÀÚ±ØÀÎÀÚ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
lupus erythematosus factor = LE factor
È«¹Ý¼º ·çǪ½ºÀÎÀÚ(ûõÚèàõ¡ì×í)
time, dose and fractionation factor, TDF factor
½Ã°£¼±·®ºÐÇÒÀÎÀÚ
anti-lymphocyte globulin
¸²ÇÁ±¸ Çױ۷κҸ°
antigen, lymphocyte defined (LD)
¸²ÇÁ±¸ Ç¥¸éÇ׿ø, LDÇ׿ø
atypical lymphocyte
ÀÌÇü<ºñÁ¤Çü>¸²ÇÁ±¸(?Ë´).
cytotoxic T lymphocyte (CTL)
¼¼Æ÷µ¶¼ºT¸²ÇÁ±¸
effector T lymphocyte
ÀÛµ¿T¸²ÇÁ±¸
effector lymphocyte
ÀÛµ¿¸²ÇÁ±¸.
granulocyte-monocyte-lymphocyte antigens
°ú¸³±¸´Ü±¸¸²ÇÁ±¸Ç׿ø
granulocyte-platelet-lymphocyte antigens
°ú¸³±¸Ç÷¼ÒÆÇ¸²ÇÁ±¸Ç׿ø
hodgkins disease,lymphocyte predominance
¸²ÇÁ±¸ ÇöÀúÇü
killer lymphocyte
»ìÇØ¸²ÇÁ±¸
large lymphocyte
´ë¸²ÇÁ±¸(¡Ï¹).
large lymphocyte
Å«¸²ÇÁ±¸
large lymphocyte
´ë¸²ÇÁ±¸(?Ë´).
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½